These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 3265362)
1. Marker discrepancy as a diagnostic criterion for lymphoid neoplasms. Sun T; Ngu M; Henshall J; Cuomo J; Eisenberg A; Benn P; Allen SL Diagn Clin Immunol; 1988; 5(6):393-9. PubMed ID: 3265362 [TBL] [Abstract][Full Text] [Related]
2. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules. Wilkerson MJ; Dolce K; Koopman T; Shuman W; Chun R; Garrett L; Barber L; Avery A Vet Immunol Immunopathol; 2005 Jul; 106(3-4):179-96. PubMed ID: 15963817 [TBL] [Abstract][Full Text] [Related]
3. Reactivity of acute lymphoblastic leukemia and normal bone marrow cells with the monoclonal anti-B-lymphocyte antibody, anti-Y 29/55. Hirt A; Baumgartner C; Forster HK; Imbach P; Wagner HP Cancer Res; 1983 Sep; 43(9):4483-5. PubMed ID: 6603266 [TBL] [Abstract][Full Text] [Related]
4. Leu-9 (CD 7) positivity in acute leukemias: a marker of T-cell lineage? Ben-Ezra J; Winberg CD; Wu A; Rappaport H Hematol Pathol; 1987; 1(3):147-56. PubMed ID: 2472373 [TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibody studies in B(non-T)-cell malignancies. Shimoyama M; Minato K; Tobinai K; Nagai M; Hirose M Jpn J Clin Oncol; 1983 Sep; 13(3):477-88. PubMed ID: 6417373 [TBL] [Abstract][Full Text] [Related]
6. [Analyses of the rearrangement of T-cell receptor- and immunoglobulin genes in the diagnosis of lymphoproliferative disorders]. Griesser DH Veroff Pathol; 1995; 144():1-109. PubMed ID: 7856305 [TBL] [Abstract][Full Text] [Related]
7. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases]. Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665 [TBL] [Abstract][Full Text] [Related]
8. Two new monoclonal antibodies, Lym-1 and Lym-2, reactive with human B-lymphocytes and derived tumors, with immunodiagnostic and immunotherapeutic potential. Epstein AL; Marder RJ; Winter JN; Stathopoulos E; Chen FM; Parker JW; Taylor CR Cancer Res; 1987 Feb; 47(3):830-40. PubMed ID: 3542194 [TBL] [Abstract][Full Text] [Related]
9. CD56+CD7+ stem cell leukemia/lymphoma with D2-Jdelta1 rearrangement. Yoshida T; Kimura N; Sawada H; Suematsu E; Nagano M; Akiyoshi T; Motomura S; Kikuchi M; Nishimura J; Tamura K Intern Med; 1999 Jul; 38(7):547-55. PubMed ID: 10435360 [TBL] [Abstract][Full Text] [Related]
10. Molecular genetic approaches for the diagnosis of clonality in lymphoid neoplasms. Willman CL; Griffith BB; Whittaker M Clin Lab Med; 1990 Mar; 10(1):119-49. PubMed ID: 2184975 [TBL] [Abstract][Full Text] [Related]
12. The immunophenotype of blast transformation of chronic myelogenous leukemia: a high frequency of mixed lineage phenotype in "lymphoid" blasts and A comparison of morphologic, immunophenotypic, and molecular findings. Khalidi HS; Brynes RK; Medeiros LJ; Chang KL; Slovak ML; Snyder DS; Arber DA Mod Pathol; 1998 Dec; 11(12):1211-21. PubMed ID: 9872654 [TBL] [Abstract][Full Text] [Related]
13. Analysis of the clinical and biological significance of lymphoid phenotypes in acute leukemia. Greaves MF Cancer Res; 1981 Nov; 41(11 Pt 2):4752-66. PubMed ID: 7028250 [TBL] [Abstract][Full Text] [Related]
14. Flow cytometry in the differential diagnosis of lymphocyte-rich thymoma from precursor T-cell acute lymphoblastic leukemia/lymphoblastic lymphoma. Li S; Juco J; Mann KP; Holden JT Am J Clin Pathol; 2004 Feb; 121(2):268-74. PubMed ID: 14983942 [TBL] [Abstract][Full Text] [Related]
15. Lymphoproliferative disorder of granular lymphocytes: nine cases including one with features of CD56 (NKH1)-positive aggressive natural killer cell lymphoma. Nichols GE; Normansell DE; Williams ME Mod Pathol; 1994 Oct; 7(8):819-24. PubMed ID: 7530849 [TBL] [Abstract][Full Text] [Related]
16. Multiple myeloma: an immunologic profile. IV. The EA rosette-forming cell is a Leu-1 positive immunoregulatory B cell. MacKenzie MR; Paglieroni TG; Warner NL J Immunol; 1987 Jul; 139(1):24-8. PubMed ID: 2953812 [TBL] [Abstract][Full Text] [Related]
17. Phenotypic heterogeneity and aberrant markers expression in T-cell leukemia. Babusíková O; Glasová M; Koníková E; Kusenda J; Cáp J; Gyárfás J; Koubek K Neoplasma; 1998; 45(3):128-34. PubMed ID: 9717523 [TBL] [Abstract][Full Text] [Related]
18. Peripheral T-cell lymphoma with aberrant expression of CD79a and CD20: a diagnostic pitfall. Yao X; Teruya-Feldstein J; Raffeld M; Sorbara L; Jaffe ES Mod Pathol; 2001 Feb; 14(2):105-10. PubMed ID: 11235901 [TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibody against a membrane antigen characterizing leukemic human B-lymphocytes. Forster HK; Gudat FG; Girard MF; Albrecht R; Schmidt J; Ludwig C; Obrecht JP Cancer Res; 1982 May; 42(5):1927-34. PubMed ID: 6175400 [TBL] [Abstract][Full Text] [Related]
20. Flow cytometric analysis of cell-surface and intracellular antigens in leukemia diagnosis. Knapp W; Strobl H; Majdic O Cytometry; 1994 Dec; 18(4):187-98. PubMed ID: 7534675 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]